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Abstract . We studied the effects of elaidic acid (EA) has on the anti-tumor effect of 5-fluorouracil (FU). 
Examining the 5 FU sensitivity in mouse lung canc巴rcel line LL2, and mouse colorectal cancer cel lines 
CT26 and CMT93, CMT93 showed low sensitivity. The increased growth inhibitory effects in CT26, CMT93, 
and LL2 cels wer巴 10】， 1.2-,and 1.1-times, respectively, on concurrent treatment with EA at an apoptosis戸
inducing concentration and らFUat a concentration of IC50. On examining aldehyde dehydrogenase (ALDH) 
activity changes in the cancer stem cells in this case, it was found to hav巴 beenincreased 3.8 fold by 
simultaneous treatment with 5-FU and EA in CT26 and LL2 cels, but 1.5-fold in CMT93 cels. In addition, 
considering the expression of nucleostemin as a stem cel marker, in simultaneous treatment with 5】FU
and EA, and treatm巴ntwith EA alone, the expression was increased in CT26 and LL2 cels, whereas the 
expression level did not change in CMT93 cels. The foregoing suggests that, rather than altering the 5-FU 
sensitivity of canc巴rcels, EA might promote the survival of cancer stem cels. The results suggest that the 
content of the diet during chemotherapy is a relevant issue. 



















細胞培養： 10%（ウシ胎児血清， fetalbovine 
serum, FBS, Sigma Chemical Co., St. Louis, MO, 
USA）および2%p巴nicilin戸StreptomycinSolution含
有 D-MEMで37℃、 5%C02下で培養した CT26（マ
ウス大腸癌細胞株、 Dr.Fidler [MD Anderson Cancer 
Center］から供与）およびCMT93（マウス大腸癌
細胞株）、 LL2（マウス肺癌細胞株、いずれも DS











(5目FU）は Sigma【Aldrich(St. Louis, MO, USA）か
ら購入し、それぞれ 100%エタノール、 phosphate
buffered saline (PBS, Sigma）で希釈し使用した。ま
た、テトラゾリウム化合物［3-(4,5四dimethylthiazol2-
yl）ふ（3『carbo町 methoxyphenyl)-2-(4』sulfophenyl)
2H tetrazolium, inner salt (MTS）試薬（CellTit巴r
96 AQueous One Solution Reagent, Promega 
Biosciences, Inc. San Louis Obispo, CA, USA）、












cells/well）を播き、 6時間後に 5FU処理した。 24時
間後に 20%MTS試薬を加え、 1時間後492nmで吸
光度を計測した。
Reverse transcription-polymerase chain reaction 
(RT-PCR) : Trizol reagent (Molecular Res巴arch
Center Inc., Cincinnati, OH, USA）を用い、細胞
より RNAを単離し、残存 DNAを除去するため
DNase処理を行った。 HighCapacity cDNA Reverse 
Transcription Kit (Applied Biosystems, Rockville, 





で あ る glyceraldehyde-3-phosphatedehydrogenase 
(GAPDH）を loadingcontrolとして用いた。なお、
Th巴rmalreactionは以下の条件で反応させた。 95℃
x 5min× lcycle (95℃ x 30sec-Tm値× 30sec






に培地を除去し、 AssayBuffer ・ Activated r巴agent
Lower primer 
GAPDH •5 ’－ TGTGTCCGTCGTGGATCTGA 同3’ 5’ー TTGCTGTTGAAGTCGCAGGAG-3'一………一……………ω………………眠、一……h…………一………一…………ー即時





















































































































Fig. 1. Effect of elaidic acid on growth and metastasis of CT26 cels 
(A) Diameter of subcutaneous tumor of CT26 cels. (B D) Metastases to the peritoneum但）， liver (C), 
and lung (D). Mice were admin】stratedintraperitoneally with vehicle (70% ethanol), oleic acid (OA 
10 rg /kg body weight). or elaidic acid (EA 10 mg /kg body weight). Bar, mean of results of 6 mice 
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Fig. 2. E旺ectof elaidic acid on 5 FU cytotoxicity in cancer cels by concurrent 
treatment of the elaidic acid and 5 FU 
CT26 (A). LL2 (BJ and CMT93 (C) cels were treated with elaidic acid (EA) (10 
μg /mL or 20 μg /mL) and 5-FU (1 μg /mL or 2 μg /mL) for 24 hrs. Error bars, 
SD 
Fig. 3. E旺ectof elaidic acid pretreatment 
on 5-FU cytotoxicity in cancer cels. 
CT26 (A). LL2 (B) and CMT93 (C) cels 
were pretreated with elaidic acid (EA) 
(20 μg/mL) for 24 hrs. After that, the 
cels were treated with 5 FU (1 μg/mL) 
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Fig.4. Effect of elaidic acid on CD133 and nucleostemin expression in 5-FU treated 
cancer cels 
(A, C) The expression of CD133 and nucleostemine (NS) are a cancer stem cel marker 
when treated with elaidic acid (20 μg /mL) and 5-FU (lμg /mL, 2μg /mL). (B, D) Graphs 
showing gene expression quant1自edbased on the representative results. C: untreated 
cels, F: cells treated with 5 FU, E: cels treated with elaidic acid. EF or E+F: cells 
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Fig. 5. Effect of elaidic acid on ALDH activity in cancer cels. 
CT26 (A). LL2 (B) and CMT93 (C) cels were treated with elaidic acid (EA) and 5 FU. (D) 
From the results indicated in the panels A-C. ALDH activity in the three cells were 
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